Abiprot™ – Breakthrough biologics technology platform

Our proprietary platform technology AbiprotTM can identify high-affinity antibody binding sites in any given protein with single amino acid resolution. It is based on using a tailored molecular reporter system and proteomics. The platform yields detailed sequence and structure information for epitope identification and development.

AbiprotTM works well with both soluble and membrane bound proteins, and, in some instances, we can also control the pharmacology of our antibodies by careful selection of epitopes to yield either antagonistic or agonistic antibodies.